News

Number Title Author Date
Notice
Dear shareholders
alteogen | 2024.03.27 | Votes 0 | Views 59
alteogen 2024.03.27
Notice
Alteogen announces amendment to license agreement with MSD.
alteogen | 2024.02.24 | Votes 0 | Views 543
alteogen 2024.02.24
Notice
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile
alteogen | 2023.09.06 | Votes 0 | Views 1361
alteogen 2023.09.06
Notice
Hyaluronidase : A new way to be excluded from drug price negotiations under IRA
alteogen | 2023.08.01 | Votes 0 | Views 1541
alteogen 2023.08.01
Notice
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products
alteogen | 2023.01.06 | Votes 0 | Views 3364
alteogen 2023.01.06
Notice
Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
alteogen | 2023.01.06 | Votes 0 | Views 2056
alteogen 2023.01.06
Notice
Alteogen Enters Into an Exclusive License Agreement With Intas to Develop and Commercialize Two Products
alteogen | 2023.01.06 | Votes 0 | Views 1841
alteogen 2023.01.06
Notice
Alteogen Enters into a Global License Agreement with a Top Ten Pharmaceutical Company for Use of Its Hybrozyme™ Technology
alteogen | 2023.01.06 | Votes 0 | Views 1871
alteogen 2023.01.06
Notice
Alteogen Enters into a Non-exclusive License Agreement with a Global Pharmaceutical Company for Use of Its Hybrozyme™Technology
alteogen | 2023.01.06 | Votes 0 | Views 1608
alteogen 2023.01.06
19
Alteogen and Lynkogen Enter into an Exclusive Option Agreement
alteogen | 2018.07.04 | Votes 0 | Views 2235
alteogen 2018.07.04
18
18 January 2018 Bio & Medicine Alteogen to seek US approval for clinical trials of Eylea biosimilar
alteogen | 2018.05.28 | Votes 0 | Views 2483
alteogen 2018.05.28
17
23 Aug. 2017 Alteogen set to start phase I trial of ADC product in Korea
alteogen | 2018.05.28 | Votes 0 | Views 1579
alteogen 2018.05.28
16
26 APR 2017 Alteogen partners with Cristalia to develop long-acting growth hormone
alteogen | 2018.05.28 | Votes 0 | Views 1577
alteogen 2018.05.28
15
20 APR 2017 Alteogen to enter late-stage study of Herceptin biosimilar
alteogen | 2018.05.28 | Votes 0 | Views 1426
alteogen 2018.05.28
14
29 MAR 2017 Korean firm to transfer biosimilar tech to Chinese partner
alteogen | 2018.05.28 | Votes 0 | Views 1449
alteogen 2018.05.28
13
29 DEC 2016 Alteogen patents
alteogen | 2018.05.28 | Votes 0 | Views 1386
alteogen 2018.05.28
12
22 DEC 2016 Alteogen clears phase 1 trial of Herceptin biosimilar in Canada
alteogen | 2018.05.28 | Votes 0 | Views 1503
alteogen 2018.05.28
11
7 Oct 2016 Alteogen receives patent in Japan
alteogen | 2018.05.28 | Votes 0 | Views 1415
alteogen 2018.05.28
10
7 Mar 2016 Additional N-glycosylation in the N-terminal region of recombinant human alpha-1 antitrypsin enhances the circulator
alteogen | 2018.05.28 | Votes 0 | Views 1276
alteogen 2018.05.28